## Abstract Within a novel series of 2‐oxazolidinones developed in the past by Sanofi‐Synthélabo, SL25.1188 ((__S__)‐5‐methoxymethyl‐3‐[6‐(4,4,4‐trifluorobutoxy)benzo[__d__]isoxazol‐3‐yl]oxazolidin‐2‐one), a compound that inhibits selectively and competitively MAO‐B in human and rat brain (Ki value
Radiosynthesis of [11C]SL25.1188 via [11C]CO2 fixation for imaging monoamine oxidase B
✍ Scribed by Neil Vasdev; Oleg Sadovski; Armando Garcia; Frédéric Dollé; Jeffrey H. Meyer; Sylvain Houle; Alan A. Wilson
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- French
- Weight
- 153 KB
- Volume
- 54
- Category
- Article
- ISSN
- 0022-2135
No coin nor oath required. For personal study only.
✦ Synopsis
Carbon‐11‐labelled (S)‐5‐methoxymethyl‐3‐[6‐(4,4,4‐trifluorobutoxy)benzo[d]isoxazol‐3‐yl]oxazolidin‐2‐[^11^C]‐one ([^11^C]SL25.1188), a promising reversibly binding radiotracer for imaging central monoamine oxidase B, was rapidly prepared via an intramolecular cyclization reaction in an automated one‐pot procedure directly from [^11^C]CO~2~, thereby precluding the use of [^11^C]COCl~2~. Formulated [^11^C]SL25.1188 was isolated in 12 ± 1% uncorrected radiochemical yield, based on starting [^11^C]CO~2~, with a specific activity of 37 ± 2 GBq/µmol at the end of synthesis (30 min; n = 3). Radiochemical and enantiomeric purities were both >99%. The methodology described herein offers an efficient production of [^11^C]SL25.1188 at ambient temperature and is suitable for human imaging studies.
📜 SIMILAR VOLUMES
## Abstract Recently, a new 2‐(iodophenyl)imidazo[1,2‐__a__]pyridineacetamide series has been developed as iodine‐123‐labelled radioligands for imaging the peripheral benzodiazepine receptors using single photon emission tomography. Within this series, 2‐[6‐chloro‐2‐(4‐iodophenyl)‐imidazo[1,2‐__a__
## Abstract SSR180575 (7‐chloro‐__N__,__N,__5‐trimethyl‐4‐oxo‐3‐phenyl‐3,5‐dihydro‐4__H__‐pyridazino[4,5‐__b__]indole‐1‐acetamide) is the lead compound of an original pyridazinoindole series of potent and highly selective TSPO (peripheral benzodiazepine receptor) ligands. Isotopic labeling of SSR18